{
    "clinical_study": {
        "@rank": "88899", 
        "acronym": "VIDI", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D supplement", 
                "arm_group_type": "Active Comparator", 
                "description": "Vitamin D supplement according to national guidelines (10 ug/day) from 2 weeks to 2 years of age"
            }, 
            {
                "arm_group_label": "Vitamin D supplement at 30 ug/day", 
                "arm_group_type": "Active Comparator", 
                "description": "Vitamin D supplement at 30 ug/day from 2 weeks to 2 years of age"
            }
        ], 
        "brief_summary": {
            "textblock": "The study is a randomized, controlled, double blinded study evaluating the effect of\n      recommended (400 IU) and 1 200 IU daily vitamin D substitution, given from 2 weeks to 2\n      years of age, on growth, bone development, neurologic and cognitive development, frequence\n      of infectious diseases, allergic symptoms, and development of immunoregulation assessed at 2\n      years of age."
        }, 
        "brief_title": "Vitamin D Intervention in Infants", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Vitamin D Status", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Infants born at term (37-42 wks, weight appropriate for gestational age) are included\n             in the study\n\n        Exclusion Criteria:\n\n          -  Non Caucasian mother\n\n          -  Any continuous regular medication of mother\n\n          -  Treatment at neonatal intensive care unit\n\n          -  Antibiotic treatment of the infant\n\n          -  Congenital malformations of the newborn\n\n          -  Treatment with ventilation support (continuous nasal positive airway pressure) for\n             over 24 hours\n\n          -  Glucose infusion of the newborn\n\n          -  Neurological symptoms of the newborn\n\n          -  Phototherapy for jaundice of the newborn\n\n          -  Need for nasogastric feeding of the newborn"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "5 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01723852", 
            "org_study_id": "VIDI-2012-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vitamin D supplement at 30 ug/day", 
                "intervention_name": "Vitamin D at 30 ug/day", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Vitamin D supplement", 
                "intervention_name": "Vitamin D at 10 ug/day", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Vitamin D", 
            "Infectious diseases", 
            "cognitive development", 
            "Bone mineral density", 
            "Immunoregulation", 
            "Allergy", 
            "Growth"
        ], 
        "lastchanged_date": "December 4, 2013", 
        "link": {
            "description": "Study web-page in Finnish", 
            "url": "http://www.helsinki.fi/d-vitamiinitutkimus"
        }, 
        "location": {
            "contact": {
                "email": "janni.rosendahl@hus.fi", 
                "last_name": "Jenni Rosendahl, MD", 
                "phone": "+35894711"
            }, 
            "contact_backup": {
                "email": "otto.helve@helsinki.fi", 
                "last_name": "Otto Helve, MD, PhD", 
                "phone": "+35894711"
            }, 
            "facility": {
                "address": {
                    "city": "Helsinki", 
                    "country": "Finland", 
                    "zip": "00029"
                }, 
                "name": "K\u00e4til\u00f6opisto Maternity Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Jenni Rosendahl, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Heli Viljakainen, PhD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Vitamin D Intervention in Infants", 
        "overall_contact": {
            "email": "elisa.holmlund@helsinki.fi", 
            "last_name": "Elisa Holmlund-Suila, MD", 
            "phone": "+35894711"
        }, 
        "overall_contact_backup": {
            "email": "otto.helve@helsinki.fi", 
            "last_name": "Otto Helve, MD, PhD", 
            "phone": "+358505824426"
        }, 
        "overall_official": {
            "affiliation": "Helsinki University Central Hospital, Children's Hospital", 
            "last_name": "Sture Andersson, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Finland: Finnish Medicines Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Measurement of growth at 2 years of age", 
                "measure": "Growth", 
                "safety_issue": "No", 
                "time_frame": "2 years of age"
            }, 
            {
                "description": "By means of questionnaires and, on a randomly selected group of study subjects, cognitive function testing to assess neurologic and cognitive development", 
                "measure": "Neurologic and cognitive development", 
                "safety_issue": "No", 
                "time_frame": "At 2 years of age"
            }, 
            {
                "description": "Assessment of the frequency of allergic symptoms and infections by means of questionnaires, hospital discharge records and prescription data.", 
                "measure": "Frequency of allergic symptoms and infection", 
                "safety_issue": "No", 
                "time_frame": "At 2 years of age"
            }, 
            {
                "description": "Assessment of the tolerogenic properties of T-cells and dendritic cell function from blood sample in a subgroup of 100 study subjects.", 
                "measure": "Development of immunoregulation", 
                "safety_issue": "No", 
                "time_frame": "At 2 years of age"
            }, 
            {
                "description": "Bone mineral density is measured by dual energy x-ray absorptiometry and peripheral quantitative computerized tomography", 
                "measure": "Bone mineral density", 
                "safety_issue": "No", 
                "time_frame": "2 years of age"
            }
        ], 
        "reference": {
            "PMID": "22933541", 
            "citation": "Holmlund-Suila E, Viljakainen H, Hytinantti T, Lamberg-Allardt C, Andersson S, M\u00e4kitie O. High-dose vitamin d intervention in infants--effects on vitamin d status, calcium homeostasis, and bone strength. J Clin Endocrinol Metab. 2012 Nov;97(11):4139-47. doi: 10.1210/jc.2012-1575. Epub 2012 Aug 29."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01723852"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Helsinki University Central Hospital", 
            "investigator_full_name": "Sture Andersson", 
            "investigator_title": "Professor of Neonatology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Helsinki University Central Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "The Finnish Governmental Special Subsidy for Health Sciences Research", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "P\u00e4ivikki and Sakari Sohlberg Foundation, Finland", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Finska L\u00e4kares\u00e4llskapet", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Helsinki University Central Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}